Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7-9th Sep 2015

WHO Product Development for Vaccines Product Development Advisory Committee, WHO Product Development for Vaccines Advisory Committee

Research output: Contribution to journalArticlepeer-review

Abstract

There are more vaccines in development, against a greater number of pathogens, than ever before. A challenge with this exceptional level of activity and investment is how to select and resource the most promising approaches to have the most significant impact on public health. The WHO Product Development for Vaccines Advisory Committee (PDVAC) was established in 2014 to provide strategic advice and recommendations to WHO for vaccines in clinical development that could have a significant impact on public health in low and middle income countries. On 7-9th September 2015, PDVAC was convened for the second time, when the committee reviewed vaccine developments in 24 disease areas. This report summarises the key recommendations from that consultation.

Original languageEnglish (US)
Pages (from-to)2865-2869
Number of pages5
JournalVaccine
Volume34
Issue number26
DOIs
StatePublished - Jun 3 2016

Keywords

  • Candidate
  • LMIC
  • PPC
  • Product development
  • Vaccine

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7-9th Sep 2015'. Together they form a unique fingerprint.

Cite this